Sale of 19,651 shares at $18.49 per share.
Reporting Person Plump Andrew Stewart · Officer Title President, R&D · Transaction Code S
Traded Aug 19, 2026 · Disclosed Aug 21, 2026
Source: SEC Form 4 · 0001493152-26-039693 · filed 2026-08-21 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "TAKEDA PHARMACEUTICAL CO LTD (TAK)." Disclosed 2026-08-21. https://desqlong.com/cards/0001493152-26-039693-1 (retrieved 2026-09-26).